The Conference Forum
More advertising solutions!
JobWatch offers several advertising opportunities, including print ads in our publications or online web ads and company profiles. Plus, you can post other career resources like training programs, webinars and academic programs.


Reach more professionals with your job posting! Post your open positions on JobWatch and they will also appear complimentary on ACRP's Career Center as part of our partnership! Post your jobs now >>

Welcome to JobWatch--your one-stop resource for career and educational information!

JobWatch is a job posting and career development site designed exclusively for clinical research professionals of all levels. Job seekers can easily post and update resumes, apply directly for open positions and sign up for e-mail alerts for new positions. It is also the perfect resource to learn more about upcoming conferences on clinical research-related topics or register for training and academic degree programs for careervdevelopment and advancement.

Sign up for your free account and find your next opportunity right now!

Keep the discussion going--join our Group on LinkedIn!


Job Search

Search job title only


Job Seeker Login

Employer Login

Have questions or feedback?
E-mail jobwatch@centerwatch.com.


Career-Related News From Around The Industry


Astrazeneca, University of Cambridge form joint Ph.D., clinical research scholarships

AstraZeneca and the University of Cambridge have formed three new joint schemes to support more than 80 Ph.D. scholarships and eight clinical lectureships over the next five years, spanning translational science, basic and clinical research.

Celladon cuts staff, considers liquidation following bad trial results

Celladon has confirmed plans to suspend further R&D of its MYDICAR (AAV1/SERCA2a) program and its other preclinical programs, including the Stem Cell Factor (mSCF) gene therapy and SERCA2b small molecule programs.


Industry Roundup: Comings and Goings

Edge Therapeutics’ CEO Brian Leuthner receives EY Entrepreneur of the Year Award

DBV Technologies adds Dr. Hugh Sampson as chief scientific officer

Brian A. Leuthner, Edge Therapeutics’ CEO, president and co-founder, has received the EY Entrepreneur of the Year 2015 New Jersey Region Award in the Pharmaceutical & Diagnostic Private Companies category. He was selected by an independent judging panel comprising previous winners of the award, CEOs, private capital investors and other regional business leaders.
DBV Technologies, a clinical-stage specialty biopharmaceutical company, has appointed Dr. Hugh Sampson chief scientific officer. In partnership with Dr. Dupont, chairman of the company’s scientific advisory board, Sampson will lead DBV’s research team, pursuing new Viaskin applications for the treatment of food allergies, while also supporting the company’s clinical development teams.